D&B Business Directory
Meda AB
Overview
Think of Meda as a medicine middleman. The specialty pharmaceutical company buys the rights for new medications in their final stages of testing and development and readies them for sale. It works with smaller, research-based companies that don't have manufacturing or marketing operations. Meda's pharmaceuticals treat respiratory, cardiology, pain and inflammation, dermatology and central nervous system illnesses. Top sellers include nasal spray ...
Read More
Astelin, heart medicine Tambocor, painkiller Zamadol, and OTC antiseptic Betadine. Meda has manufacturing plants in France, Germany, and the US; its products are sold in about 120 countries. Generics specialist Mylan acquired Meda in a $9.9 billion transaction in 2016.
Read Less
Lars Henrik Andreas Rejnus   See more contacts
?
?
Modelled
#
Actual
?
?
Contacts
Get in Touch with 7 Principals*
  • Lars Henrik Andreas Rejnus
    Managing Director
  • Contact 2
    ?
  • Contact 3
    ?
  • Contact 4
    ?
D&B Hoovers Logo

Dynamic search and list-building capabilities

Real-time trigger alerts

Comprehensive company profiles

Valuable research and technology reports

Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Stay on top of your Business Credit File
Get full access to view your D&B business credit file now for just $39/month!
View D&B Scores & Ratings